All results

67 results for stronger study

• DOTS (20-0002)

  This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of…

  Ages

  18 Years - 99 Years

  Sexes

  All

• DoD Mastectomy

  Breast cancer is the most common type of cancer in women. Removal of the breast, called "mastectomy", is performed either when there is cancer-or an increased…

  Ages

  18 Years - N/A

  Sexes

  All

• EVOLVE

  The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid…

  Ages

  18 Years - 99 Years

  Sexes

  All

• EXPAND II

  Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic…

  Ages

  65 Years - N/A

  Sexes

  All

• Effect of Armodafinil

  Sleep deprivation slows reaction time, reduces vigilance and impairs judgment and information processing. Chronic effects include metabolic dysfunction,…

  Ages

  18 Years - 35 Years

  Sexes

  All

• Efficacy and Safety of the HAV W/AVF in Female Patients With End-Stage Renal Disease

  The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections…

  Ages

  18 Years - N/A

  Sexes

  Female

• Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT…

  Ages

  18 Years - N/A

  Sexes

  All

• Exercise to ReGain Stamina and Energy The EXERGISE Study

  About 20%-70% of breast cancer survivors experience fatigue after cancer therapy. Because epidemiologic evidence shows that old age is a risk factor for…

  Ages

  60 Years - 105 Years

  Sexes

  Female

• FASTEST Trial

  The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute…

  Ages

  18 Years - 80 Years

  Sexes

  All

• Fasting ENHANCE

  Grounded in the principles of geroscience, the proposed Fasting ENHANCE study will test whether a time restricted eating (TRE) regimen can improve cognitive…

  Ages

  65 Years - N/A

  Sexes

  All